The Europe CBD oil market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 23% during 2021-2026.
Cannabidiol (CBD) is a non-psychoactive compound obtained from resins, leaves, and flowers of the marijuana or hemp plant. To produce CBD oil, cannabidiol is extracted from the cannabis plant and is diluted with a carrier oil, such as coconut oil. CBD oil has a high content of amino acids, iron, fiber, zinc, etc. Besides having moderating effects on depression, anxiety, insomnia, seizures, etc., the oil is also used to relieve pain, improve heart health, alleviate cancer-related symptoms, treat acne, etc.
Aurora Cannabis, Diamond CBD Inc., ENDOCA, APHRIA Inc., ConnOils LLC, Elixinol Global Limited, Emblem CANNABIS, NuLeaf Naturals, LLC, CBD Ultra Limited and The Original Alternative Limited.
Request Free Sample Report: https://www.imarcgroup.com/europe-cbd-oil-market/requestsample
Europe CBD Oil Market Trends:
The increasing legalization of cannabidiol across several European countries is primarily driving the market for CBD oil. Moreover, the rising prevalence of various neurological and psychiatric disorders is also catalyzing the product demand for treating such ailments. In line with this, CBD oil-infused supplements are being increasingly adopted in cancer treatment to minimize the side effects of chemotherapy, like weight loss, nausea, fatigue, etc. Additionally, the advancing pharmaceutical industry and the increasing use of bioactive ingredients in drugs are further bolstering the product demand. Besides this, the escalating usage of CBD oil in cosmetics and personal care products due to its anti-inflammatory and anti-aging properties is expected to further strengthen the Europe CBD oil market in the coming years.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Buy full Report with Complete TOC: https://www.imarcgroup.com/checkout?id=3969&method=1
Breakup by Source:
- Marijuana Based
- Hemp Based
Breakup by Product Type:
Breakup by Product Category:
Breakup by Application:
- Food and Beverages
- Personal Care
Breakup by Distribution Channel:
Breakup by Country:
- United Kingdom
- Rest of Europe
Request Customization: https://www.imarcgroup.com/request?type=report&id=3969&flag=E
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Other Report by IMARC Group:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800